Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 709,171 | 517,553 | 137,636 | 298,395 | 171,445 |
| Marketable Securities | N/A | N/A | N/A | N/A | 19,821 |
| Receivables | 126,477 | 65,476 | 53,514 | 10,439 | 6,619 |
| Inventories | 37,166 | 19,541 | 15,644 | 6,805 | 7,870 |
| TOTAL | $894,030 | $623,609 | $219,329 | $320,806 | $210,106 |
| Non-Current Assets | |||||
| PPE Net | 1,037 | 1,354 | 1,195 | 847 | 959 |
| Investments And Advances | 22,536 | 21,564 | 16,489 | 0 | 0 |
| Intangibles | 131,674 | 156,672 | 194,049 | 32,471 | 0 |
| Other Non-Current Assets | 54,702 | 48,212 | 39,052 | 21,506 | 26,723 |
| TOTAL | $209,949 | $227,802 | $250,785 | $54,824 | $27,682 |
| Total Assets | $1,103,979 | $851,411 | $470,114 | $375,630 | $237,788 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,202 | 16,593 | 14,795 | 3,975 | 2,768 |
| Accrued Expenses | 135,950 | 104,085 | 61,268 | 53,613 | 24,295 |
| TOTAL | $147,152 | $120,678 | $76,063 | $57,588 | $27,063 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,559 | 3,101 | 6,170 | 17,621 | 3,894 |
| TOTAL | $2,559 | $3,101 | $6,170 | $17,621 | $3,894 |
| Total Liabilities | $149,711 | $123,779 | $82,233 | $75,209 | $30,957 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 122,124 | 121,450 | 117,863 | 105,654 | 102,745 |
| Common Shares | 123 | 121 | 107 | 105 | 103 |
| Retained earnings | 474,188 | 285,161 | 121,272 | 49,862 | -26,310 |
| Other shareholders' equity | 0 | 64 | 14 | 24 | -148 |
| TOTAL | $954,268 | $727,632 | $387,881 | $300,421 | $206,831 |
| Total Liabilities And Equity | $1,103,979 | $851,411 | $470,114 | $375,630 | $237,788 |